Loading market data...
Latest Top News
Show more
Torrent Pharma Oncology Facility Clears USFDA Inspection With Zero Observations In April 2026
Torrent Pharmaceuticals Ltd has confirmed that the USFDA inspection of its Bileshwarpura oncology facility in Gujarat, conducted between April 6 and April 10, 2026, concluded with zero observations. This clean report underscores the company’s strong compliance with global regulatory standards and boosts its credibility in international markets.
Stay Ahead – Explore Now! Sadbhav Lenders Reject NARCL Offer, Opt For Out-Of-Court Settlement






